PRESTIGE-AF focused on preventing recurrent stroke in patients with intracerebral haemorrhage and atrial fibrillation, involving personalised anticoagulant therapy.
REGION NORDJYLLAND (NORTH DENMARK REGION)
Danish regional health authority contributing clinical infrastructure, patient cohorts, and healthcare delivery expertise to European research consortia.
Their core work
North Denmark Region is the public health and regional development authority for the Aalborg area in northern Denmark, operating hospitals, healthcare services, and regional transport infrastructure. In H2020, they contributed clinical expertise in stroke prevention and cardiovascular medicine, participated in health workforce training, and supported innovation procurement for urban mobility. Their involvement reflects a regional government bringing real-world healthcare delivery and public service infrastructure to EU research consortia.
What they specialise in
HealthPros trained healthcare performance intelligence professionals — their largest funded project at EUR 580,164.
INDEX developed an integrated nanoparticle isolation and detection system for on-chip exosome analysis using microfluidics and optical biosensing.
SPICE supported procurement of innovative transport and mobility solutions in city environments.
RUNIN examined the role of universities in innovation and regional development, where North Denmark Region participated as a third party.
How they've shifted over time
North Denmark Region's early H2020 involvement (2016) centred on regional innovation systems and urban transport procurement — typical concerns for a public authority. From 2017 onward, their participation shifted decisively toward health and biomedical diagnostics, with projects in stroke prevention, biosensing technology, and healthcare workforce training. This evolution suggests the region increasingly channels its EU participation through its hospital system and clinical research infrastructure rather than general regional development.
Moving toward health-focused EU participation, particularly in clinical trials and advanced diagnostics — future partners should approach them through their hospital and healthcare systems.
How they like to work
North Denmark Region exclusively participates as a partner or third party — they have never coordinated an H2020 project. With 60 unique partners across 17 countries, they plug into broad European consortia rather than leading them. This is typical for a regional public body: they bring clinical infrastructure, patient populations, and real-world testing environments, while research universities and institutes handle scientific coordination.
Connected to 60 unique partners across 17 countries, indicating wide European reach despite modest project volume. Their network spans health research institutions, universities studying regional development, and urban innovation actors.
What sets them apart
As a regional health authority with its own hospital system, North Denmark Region offers something most academic partners cannot: direct access to clinical environments, patient cohorts, and real-world healthcare delivery data. For consortium builders, they represent a validated end-user and implementation site rather than another research lab. Their Aalborg base also connects to Aalborg University's strong engineering and health informatics ecosystem.
Highlights from their portfolio
- HealthProsTheir largest funded project (EUR 580,164), training a new generation of healthcare performance analysts — directly aligned with the region's role as a healthcare provider.
- PRESTIGE-AFA long-running clinical project (2017-2024) on personalised stroke prevention in high-risk patients, demonstrating sustained commitment to cardiovascular research.
- INDEXAn advanced biosensing project combining microfluidics, nanoparticles, and exosome detection — unusually technical for a public authority, suggesting strong links to local research labs.